Mechanisms of normal appearing corpus callosum injury related to pericallosal T1 lesions in multiple sclerosis using directional diffusion tensor and 1H MRS imaging
暂无分享,去创建一个
S J Nelson | R. Henry | S. Nelson | D. Pelletier | Joonmi Oh | J. Oh | R G Henry | C. Genain | D Pelletier | J Oh | C Genain
[1] Simon K Warfield,et al. Diffusion Tensor Magnetic Resonance Imaging in Multiple Sclerosis , 2005, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[2] T. Ptak,et al. Investigation of apparent diffusion coefficient and diffusion tensor anisotrophy in acute and chronic multiple sclerosis lesions. , 1999, AJNR. American journal of neuroradiology.
[3] D. Silberberg,et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.
[4] M. Filippi,et al. Primary Progressive Multiple Sclerosis , 2002, Topics in Neuroscience.
[5] P. Basser,et al. Water Diffusion Changes in Wallerian Degeneration and Their Dependence on White Matter Architecture , 2000 .
[6] P. Basser,et al. Estimation of the effective self-diffusion tensor from the NMR spin echo. , 1994, Journal of magnetic resonance. Series B.
[7] A. Thompson,et al. Major differences in the dynamics of primary and secondary progressive multiple sclerosis , 1991, Annals of neurology.
[8] R. Rudick,et al. Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.
[9] Roland G Henry,et al. Directional diffusion in relapsing‐remitting multiple sclerosis: A possible in vivo signature of Wallerian degeneration , 2003, Journal of magnetic resonance imaging : JMRI.
[10] P M Matthews,et al. In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis. , 1999, Brain : a journal of neurology.
[11] B D Trapp,et al. Axonal pathology in multiple sclerosis: relationship to neurologic disability. , 1999, Current opinion in neurology.
[12] G. Barker,et al. Lesion heterogeneity in multiple sclerosis: a study of the relations between appearances on T1 weighted images, T1 relaxation times, and metabolite concentrations , 2000, Journal of neurology, neurosurgery, and psychiatry.
[13] S. Nelson,et al. MRI lesion volume heterogeneity in primary progressive MS in relation with axonal damage and brain atrophy , 2003, Journal of neurology, neurosurgery, and psychiatry.
[14] Susan M. Chang,et al. Volume MRI and MRSI techniques for the quantitation of treatment response in brain tumors: Presentation of a detailed case study , 1997, Journal of magnetic resonance imaging : JMRI.
[15] P. Matthews,et al. Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. , 2000, Brain : a journal of neurology.
[16] G. Comi,et al. Mean diffusivity and fractional anisotropy histograms of patients with multiple sclerosis. , 2001, AJNR. American journal of neuroradiology.
[17] M Filippi,et al. Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI , 1999, Neurology.
[18] G J Barker,et al. Water diffusion is elevated in widespread regions of normal-appearing white matter in multiple sclerosis and correlates with diffusion in focal lesions , 2001, Multiple sclerosis.
[19] K. Rammohan. Axonal injury in multiple sclerosis , 2003, Current neurology and neuroscience reports.
[20] P. Bottomley. Spatial Localization in NMR Spectroscopy in Vivo , 1987, Annals of the New York Academy of Sciences.
[21] Gareth J. Barker,et al. A study of the mechanisms of normal-appearing white matter damage in multiple sclerosis using diffusion tensor imaging , 2003, Journal of Neurology.
[22] P A Narayana,et al. Cerebrospinal fluid‐suppressed high‐resolution diffusion imaging of human brain , 1997, Magnetic resonance in medicine.
[23] R M Henkelman,et al. MR properties of rat sciatic nerve following trauma , 2001, Magnetic resonance in medicine.
[24] P. Basser,et al. Diffusion tensor MR imaging of the human brain. , 1996, Radiology.
[25] S. Nelson. Analysis of volume MRI and MR spectroscopic imaging data for the evaluation of patients with brain tumors , 2001, Magnetic resonance in medicine.
[26] D B Vigneron,et al. Registration of images from sequential MR studies of the brain , 1994, Journal of magnetic resonance imaging : JMRI.
[27] V. Stevenson,et al. Magnetic resonance imaging in the monitoring of disease progression in multiple sclerosis , 1999, Multiple sclerosis.
[28] Jia Newcombe,et al. High Resolution Proton NMR Spectroscopy of Multiple Sclerosis Lesions , 1995, Journal of neurochemistry.
[29] J. Baskerville,et al. The natural history of multiple sclerosis: a geographically based study. 6. Applications to planning and interpretation of clinical therapeutic trials in primary progressive multiple sclerosis. , 1999, Brain : a journal of neurology.
[30] P. Scheltens,et al. MR of the spinal cord in multiple sclerosis: relation to clinical subtype and disability. , 1997, AJNR. American journal of neuroradiology.
[31] Cheuk Y. Tang,et al. Quantitative diffusion measurements in focal multiple sclerosis lesions: correlations with appearance on TI-weighted MR images. , 2000, AJR. American journal of roentgenology.
[32] J. Baskerville,et al. The natural history of multiple sclerosis: a geographically based study. 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation. , 1999, Brain : a journal of neurology.
[33] P M Matthews,et al. Imaging axonal damage of normal-appearing white matter in multiple sclerosis. , 1998, Brain : a journal of neurology.
[34] J. Baskerville,et al. The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. , 1999, Brain : a journal of neurology.
[35] M Rovaris,et al. Correlation of multiple sclerosis measures derived from T2-weighted, T1-weighted, magnetization transfer, and diffusion tensor MR imaging. , 2001, AJNR. American journal of neuroradiology.
[36] E. Waubant,et al. Multiple sclerosis that is progressive from the time of onset: clinical characteristics and progression of disability. , 1999, Archives of neurology.
[37] D. Le Bihan,et al. Diffusion tensor imaging: Concepts and applications , 2001, Journal of magnetic resonance imaging : JMRI.
[38] J. Coyle,et al. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies , 1991, Neuroscience.
[39] Geoff J. M. Parker,et al. 1H Magnetic resonance spectroscopy of normal appearing white matter in primary progressive multiple sclerosis , 1999, Journal of Neurology.
[40] J. Kurtzke. Rating neurologic impairment in multiple sclerosis , 1983, Neurology.
[41] V. Perry,et al. Axonal damage in acute multiple sclerosis lesions. , 1997, Brain : a journal of neurology.
[42] F. Barkhof,et al. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis , 1998, Neurology.
[43] Derek K. Jones,et al. Diffusion‐tensor MRI: theory, experimental design and data analysis – a technical review , 2002 .
[44] B. Weinshenker,et al. Natural history of multiple sclerosis. , 2005, Neurologic clinics.
[45] W. Brück,et al. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. , 2000, Brain : a journal of neurology.
[46] R. Kinkel,et al. A Wallerian degeneration pattern in patients at risk for MS , 2000, Neurology.
[47] P M Matthews,et al. Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: Assessment of the load of disease , 1990, Magnetic resonance in medicine.